Transposition and amplification of oncogene-related sequences in human neuroblastomas

Nancy E. Kohl, Naotoshi Kanda, Rhona R. Schreck, Gail Bruns, Samuel A. Latt, Fred Gilbert, Frederick W. Alt

Research output: Contribution to journalArticlepeer-review

494 Scopus citations


We have cloned a 2.0-kb EcoRI fragment of human genomic DNA (NB-19-21) which has homology to the v-myc oncogene but is distinct from the classical c-myc gene. This sequence is amplified from 25- to 700-fold in eight of nine tested human neuroblastoma cell lines which contain either homogeneously staining regions or double minutes (HSRs or DMs), the caryological manifestations of amplified genes. In the remaining line, the c-myc proto-oncogene is amplified approximately 30-fold. NB-19-21 hybridizes to a 3.2-kb cytoplasmic, poly(A)+ RNA species that is abundant only in lines in which the sequence is amplified. We propose that the gene encoding the NB-19-21-related RNA species may represent a new oncogene, which we call N-myc. NB-19-21 derives from chromosome 2; but in the five HSR-containing lines that have amplified this sequence, none has HSRs on chromosome 2. NB-19-21 is associated with DMs in a DM-containing line. A second, randomly cloned, amplified DNA segment from the HSR of one of the neuroblastoma lines is amplified in a subset of the lines in which NB-19-21 is amplified. In addition, this probe identifies a novel joint in the amplification unit of one line relative to that of the others. We suggest that, in the eight lines which have amplified NB-19-21, the amplification units are overlapping, but not identical, and that transposition of the common sequences may occur prior to amplification.

Original languageEnglish
Pages (from-to)359-367
Number of pages9
Issue number2 PART 1
StatePublished - Dec 1983


Dive into the research topics of 'Transposition and amplification of oncogene-related sequences in human neuroblastomas'. Together they form a unique fingerprint.

Cite this